Alexion Pharmaceuticals Inc. (ALXN)

Bespreek hier de kleinere aandelen van de beurs in New York
Plaats reactie
alles kan beter
Premiummember
Premiummember
Berichten: 404
Lid geworden op: 03 Aug 2017 08:03
Locatie: +9000
waarderingen: 121
Contact:

Alexion Pharmaceuticals Inc. (ALXN)

Berichtdoor alles kan beter » 12 Apr 2018 18:59

met m'n 'winst' van balta in gestapt
Alexion Pharmaceuticals has
agreed to buy Sweden's Wilson Therapeutics WTX.ST for 7.1
billion Swedish crowns ($855 million), boosting its line-up of
rare disease drugs as a wave of deal-making in the biotechnology
sector continues.
The U.S. group is acquiring the business through a cash
tender offer worth 232 crowns per share, a premium of 70 percent
compared to the closing share price on April 10.
Alexion was one of the stars of the biotech sector in the
first half of this decade, but it has stumbled more recently
following an exodus of top management and a sales practices
scandal related to Soliris, its pricey rare disease treatment.
Adding Stockholm-based Wilson will give it new therapies to
treat unusual copper-mediated disorders and marks a first step
by the new executive team in overhauling Alexion's medicine
cabinet.
The two companies said on Wednesday that investors holding a
total of 73.4 percent of Wilson's shares supported the takeover
offer.
Shares in Wilson jumped to 230.50 crowns by 1335 GMT, while
Alexion was little changed in early Nasdaq dealings.

The Swedish group's main asset is WTX101, a drug in
final-stage Phase III testing for Wilson disease, a rare genetic
condition that causes severe liver disease and serious
neurological problems. WTX101 works by removing excess copper
from the bloodstream.
"The acquisition of Wilson Therapeutics is a strong
strategic fit for Alexion given the overlap with our current
clinical and commercial focus on metabolic and neurologic
disorders, and is an important first step in rebuilding our
clinical pipeline," said Alexion Chief Executive Ludwig Hantson.
WTX101 has secured fast-track designation in the United
States, which should speed its path to market, and also has
orphan drug status in both the U.S. and Europe, which brings
certain benefits.
SunTrust Robinson Humphrey analyst Yatin Suneja said the new
drug would provide badly needed diversity to Alexion's pipeline,
assuming it proves itself in Phase III. Results from the pivotal
WTX101 trial https://clinicaltrials.gov/ct2/show/NCT03403205 are
expected later next year.
RBC Capital Markets said buying Wilson would use up much of
Alexion's cash pile but there was still scope for smaller deals.
Wilson disease affects approximately 10,000 patients in the
United States and 15,000 in the European Union.

BIOTECH DRUG RACE
There have been a slew of deals in the biotech sector this
year as drugmakers turn to promising drugs from outside to boost
sales growth. Highly priced and high-margin treatments for rare
diseases have been a particular focus for such acquisitions.
On Monday, Swiss drugmaker Novartis agreed to
acquire gene therapy specialist AveXis for $8.7
billion, following similar multibillion-dollar deals by the
likes of France's Sanofi SASY.PA and U.S.-based Celgene
.
Japan's Takeda Pharmaceutical , meanwhile, is
considering a takeover bid for London-listed Shire SHP.L .

Alexion said its acquisition of Wilson was expected to close
in the second quarter of 2018 and that it intended to finance
the acquisition through cash on hand.
Lazard is acting as financial adviser to Wilson, while
Alexion is being advised by BofA Merrill Lynch
piddybull liked last!
be the reason someone smiles today. or the reason they drink. whatever works


josymar
Forum gebruiker
Forum gebruiker
Berichten: 245
Lid geworden op: 03 Nov 2015 23:35
waarderingen: 62
Contact:

Re: ALEXION PHARMACEUTICALS INC. (ALXN)

Berichtdoor josymar » 12 Apr 2018 19:55

Alexion Pharmaceuticals is een aandeel dat ik principieel (om ethische redenen) nooit zou kopen gezien de zeer "bedenkelijke" politiek van dat bedrijf: geld binnenrijven met alle mogelijke middelen op kosten van de maatschappij. Herinner u het geval Viktor en Solaris in 2013 (zie: https://www.google.com/search?q=viktor+ ... =firefox-b).

alles kan beter
Premiummember
Premiummember
Berichten: 404
Lid geworden op: 03 Aug 2017 08:03
Locatie: +9000
waarderingen: 121
Contact:

Re: Alexion Pharmaceuticals Inc. (ALXN)

Berichtdoor alles kan beter » 13 Apr 2018 05:54

ik begrijp je.. maar toch. vervang alexion door gelijk welk bedrijf (ok, er zijn uitzonderingen) en je mag de zin gewoon kopieren.
en al zeker door gelijk welke bank. (banken = legale maffia)
be the reason someone smiles today. or the reason they drink. whatever works